Nuvalent

1 follower

‌

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectiv... Read more

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

Links

Org chart

CEO

James Porter

Collapse

CFO

Christopher Turner

Chief Medical Officer

Chief Legal Officer

Chief Development Officer

SVP, Drug Discovery

VP, Chemistry

VP, Translational Development

VP, Corporate Strategy & Portfolio Management

Matthew Metivier

VP, Human Resources

VP, IT

Shannon Dauksis

Senior Director, Program Management

Senior Director, Quality Assurance

Director, Cybersecurity & Compliance

José Rios Lizarraga

Associate Director, Formulation Sciences

Associate Director, Analytical Sciences

Teams

Leadership Team

13 members

Similar companies

FieldGuide

2 followers

Apogee Therapeutics

1 follower

PrognomiQ

1 follower

Adaptive Biotechnologies

13 followers

SOPHiA GENETICS

4 followers

Genesis Therapeutics

2 followers

Thermo Fisher Scientific

165 followers

Gilead Sciences

128 followers

Pearson

59 followers

Neuralink

60 followers

Alexion Pharmaceuticals

34 followers

Explore companies